patient schreef:
Wie is deze nieuwe klant?
16% of the total trade receivables at 31 December
2010 related to Biolex (2009, 54%). The credit risk
for the Company is limited, as Biolex is a
creditworthy company which raised $ 60 million
through a private offering in October 2008, and a
further $ 20 million in 2010. Except for Biolex, there
is one other customer that represents more than
10% of the total balance of trade receivables at
year-end 2010 (2009, no customers). None of the
invoices outstanding for this other customer is
more than 1 day overdue at 31 December 2010 and
none of these invoices is outstanding as of today.